Log in to save to my catalogue

A Japanese Bioventure Company's Application of Stem Cell Technology in Regenerative Medicine

A Japanese Bioventure Company's Application of Stem Cell Technology in Regenerative Medicine

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2130306797

A Japanese Bioventure Company's Application of Stem Cell Technology in Regenerative Medicine

About this item

Full title

A Japanese Bioventure Company's Application of Stem Cell Technology in Regenerative Medicine

Publisher

United States: Elsevier Inc

Journal title

Clinical therapeutics, 2018-11, Vol.40 (11), p.1801-1806

Language

English

Formats

Publication information

Publisher

United States: Elsevier Inc

More information

Scope and Contents

Contents

Regenerative medicine mediated by the transplantation of somatic stem cells and functional cells derived from induced pluripotent stem cells has great potential in the treatment of currently incurable diseases and thus has attracted significant public attention. To put this into practice, several functional cell lines were developed and laws regard...

Alternative Titles

Full title

A Japanese Bioventure Company's Application of Stem Cell Technology in Regenerative Medicine

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2130306797

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2130306797

Other Identifiers

ISSN

0149-2918

E-ISSN

1879-114X

DOI

10.1016/j.clinthera.2018.10.001

How to access this item